JP2007091758A5 - - Google Patents

Download PDF

Info

Publication number
JP2007091758A5
JP2007091758A5 JP2007003546A JP2007003546A JP2007091758A5 JP 2007091758 A5 JP2007091758 A5 JP 2007091758A5 JP 2007003546 A JP2007003546 A JP 2007003546A JP 2007003546 A JP2007003546 A JP 2007003546A JP 2007091758 A5 JP2007091758 A5 JP 2007091758A5
Authority
JP
Japan
Prior art keywords
composition
composition according
weight
active agent
disintegrant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007003546A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007091758A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2007091758A publication Critical patent/JP2007091758A/ja
Publication of JP2007091758A5 publication Critical patent/JP2007091758A5/ja
Withdrawn legal-status Critical Current

Links

JP2007003546A 2000-06-22 2007-01-11 固体バルサルタン医薬組成物 Withdrawn JP2007091758A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59968700A 2000-06-22 2000-06-22

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002503289A Division JP2003535895A (ja) 2000-06-22 2001-06-20 固体バルサルタン医薬組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012172246A Division JP2012211200A (ja) 2000-06-22 2012-08-02 固体バルサルタン医薬組成物

Publications (2)

Publication Number Publication Date
JP2007091758A JP2007091758A (ja) 2007-04-12
JP2007091758A5 true JP2007091758A5 (enExample) 2007-09-13

Family

ID=24400655

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2002503289A Withdrawn JP2003535895A (ja) 2000-06-22 2001-06-20 固体バルサルタン医薬組成物
JP2007003546A Withdrawn JP2007091758A (ja) 2000-06-22 2007-01-11 固体バルサルタン医薬組成物
JP2012172246A Pending JP2012211200A (ja) 2000-06-22 2012-08-02 固体バルサルタン医薬組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002503289A Withdrawn JP2003535895A (ja) 2000-06-22 2001-06-20 固体バルサルタン医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012172246A Pending JP2012211200A (ja) 2000-06-22 2012-08-02 固体バルサルタン医薬組成物

Country Status (21)

Country Link
EP (2) EP1296677A2 (enExample)
JP (3) JP2003535895A (enExample)
KR (2) KR100525341B1 (enExample)
CN (2) CN1221256C (enExample)
AU (2) AU2001285768B2 (enExample)
BR (1) BR0111868A (enExample)
CA (1) CA2411882C (enExample)
CZ (1) CZ20024180A3 (enExample)
EC (1) ECSP024389A (enExample)
HK (1) HK1052868A1 (enExample)
HU (1) HUP0301390A3 (enExample)
IL (2) IL153428A0 (enExample)
MX (1) MXPA02012683A (enExample)
NO (1) NO20026123L (enExample)
NZ (2) NZ522953A (enExample)
PL (1) PL358290A1 (enExample)
RU (1) RU2333757C2 (enExample)
SG (1) SG162605A1 (enExample)
SK (1) SK18062002A3 (enExample)
WO (1) WO2001097805A2 (enExample)
ZA (1) ZA200210359B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ511938A (en) * 1998-12-23 2004-02-27 Novartis Ag Use of AT-1 receptor antagonist or treating diseases associated with an increase of AT-1 receptor
US7468390B2 (en) 2002-01-17 2008-12-23 Novartis Ag Methods of treatment and pharmaceutical composition
DE60315795T2 (de) * 2002-01-17 2008-06-05 Novartis Ag Pharmazeutische zusammensetzung enthaltend valsartan und nep-inhibitoren
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
TWI299663B (en) * 2002-05-14 2008-08-11 Novartis Ag Methods of treatment
KR20080083071A (ko) 2003-08-08 2008-09-12 아지노모토 가부시키가이샤 나테글리니드 함유 제제
WO2006021443A2 (en) * 2004-08-26 2006-03-02 Novartis Ag Composition comprising an at1 receptor blocker and a macrolide t-cell immunomodulator
EA015108B1 (ru) 2004-12-24 2011-06-30 КРКА, д.д., НОВО МЕСТО Способ получения твердой фармацевтической композиции, содержащей валсартан
JP2009001520A (ja) * 2007-06-21 2009-01-08 Kowa Co ジフェンヒドラミン含有固形製剤
CN101888829A (zh) 2007-10-09 2010-11-17 诺瓦提斯公司 缬沙坦的药物制剂
WO2009059605A1 (en) * 2007-11-08 2009-05-14 University Of Copenhagen Small scale solid state screening
EP2067470A1 (en) * 2007-12-03 2009-06-10 Laboratorios Lesvi, S.L. Pharmaceutical compositions containing valsartan and process for its preparation
SI2536396T1 (sl) 2010-02-16 2017-01-31 KRKA, tovarna zdravil, d.d.,Novo mesto Postopek za pripravo oralnih trdnih odmernih oblik, ki obsegajo valsartan
CN102362865B (zh) * 2011-10-28 2013-06-26 山东司邦得制药有限公司 一种含有盐酸贝尼地平和缬沙坦的复方制剂及其应用
WO2013098578A1 (en) 2011-12-31 2013-07-04 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Immediate release pharmaceutical composition of valsartan hydrochlorothiazide
WO2013098576A1 (en) 2011-12-31 2013-07-04 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Immediate release pharmaceutical composition of valsartan
CN103599084B (zh) * 2013-11-22 2018-10-30 威海迪素制药有限公司 一种降压组合物
CN112826806A (zh) * 2021-01-20 2021-05-25 海南皇隆制药股份有限公司 一种缬沙坦片制备方法和缬沙坦片
CN112807286A (zh) * 2021-01-20 2021-05-18 海南皇隆制药股份有限公司 一种缬沙坦分散片制备方法和缬沙坦分散片
EP4295839A1 (en) 2022-06-20 2023-12-27 KRKA, d.d., Novo mesto Combination of valsartan and indapamide

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0443983B1 (de) 1990-02-19 1996-02-28 Ciba-Geigy Ag Acylverbindungen
CA2184712A1 (en) * 1994-03-17 1995-09-21 Marc De Gasparo Treatment of diabetic nephropathy with valsartan
CN1142793C (zh) * 1995-06-07 2004-03-24 G·D·瑟尔公司 环氧-甾族化合物醛甾酮拮抗剂和血管紧张肽ⅱ拮抗剂联合治疗用于治疗充血性心衰
JPH11513395A (ja) * 1995-10-06 1999-11-16 ノバルティス・アクチエンゲゼルシャフト 虚血後腎不全の予防および処置並びに虚血腎臓の保護のためのａｔ１−レセプターアンタゴニスト
ATE230263T1 (de) * 1996-02-29 2003-01-15 Novartis Erfind Verwalt Gmbh At1 rezeptor antagonist zur anregung von apoptosis
US6509038B2 (en) * 1996-05-20 2003-01-21 Janssen Pharmaceutica N.V. Antifungal compositions with improved bioavailability
GB9613470D0 (en) * 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
US6362371B1 (en) * 1998-06-08 2002-03-26 Advanced Medicine, Inc. β2- adrenergic receptor agonists
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
NZ511938A (en) * 1998-12-23 2004-02-27 Novartis Ag Use of AT-1 receptor antagonist or treating diseases associated with an increase of AT-1 receptor
US20040023840A1 (en) * 2000-04-12 2004-02-05 Marc De Gasparo Combination of organic compounds

Similar Documents

Publication Publication Date Title
JP6122098B2 (ja) オルメサルタンメドキソミルとロスバスタチンまたはその塩とを含む医薬組成物
JP5553452B2 (ja) ブリバラセタムを含む医薬組成物
JP6875407B2 (ja) Ｊａｋキナーゼ阻害剤またはその薬剤的に許容される塩を含有する医薬組成物
JP2010031019A (ja) 薬物高含量錠剤
JP2003535895A5 (enExample)
JP6068765B2 (ja) 薬学的複合製剤
WO2011160541A1 (zh) 托伐普坦固体分散体及其制备方法
JP4970452B2 (ja) メトホルミン徐放性錠剤およびその製造方法
JP2017518985A (ja) アリサルタン・イソプロキシル固体分散体及び医薬組成物
AU2018369664A1 (en) Controlled release formulation
AU2005338461A1 (en) Pharmaceutical compositions of telmisartan
TW201601719A (zh) 阿利沙坦酯固體分散體及含有該固體分散體的藥物組合物
US20160008375A1 (en) Pharmaceutical formulations comprising quetiapine and escitalopram
JP2002522377A (ja) イブプロフェンおよびドンペリドンを含んで成る製薬組成物
WO2014058047A1 (ja) カルシウム拮抗薬／アンジオテンシンｉｉ受容体拮抗薬含有医薬製剤の製造方法
WO2011080706A1 (en) Enhanced solubility of ziprasidone
EP3307249A1 (en) Pharmaceutical composition comprising ivabradine hydrochloride and method for preparation thereof
EP1797872A1 (en) Telmisartan-containing pharmaceutical compositions for oral intake
JP6336078B2 (ja) 医薬組成物
JP6321131B2 (ja) アムロジピン含有配合錠の溶出性改善方法
JP2007530510A (ja) トラセミドとマトリックス形成ポリマーとを含む持続放出型組成物（ｐｒｏｌｏｎｇｅｄ−ｒｅｌｅａｓｅｃｏｍｐｏｓｉｔｉｏｎ）
CN112057427A (zh) 一种含有布鲁顿氏酪氨酸激酶抑制剂的口服固体片剂及其制备方法
JP5910311B2 (ja) 医薬錠剤およびその製造方法
JP2010516712A5 (enExample)
WO2008141751A2 (en) Pharmaceutical compositions comprising oxcarbazepine